학술논문

Early Stage HER2-Positive Breast Cancers Not Achieving a pCR From Neoadjuvant Trastuzumab- or Pertuzumab-Based Regimens Have an Immunosuppressive Phenotype
Document Type
Article
Source
In Clinical Breast Cancer October 2018 18(5):410-417
Subject
Language
ISSN
1526-8209